Prostaglandin E1 protects dog pancreas from ischemia-reperfusion injury

Pancreas. 1994 May;9(3):354-60. doi: 10.1097/00006676-199405000-00012.

Abstract

Effects of prostaglandin (PG) E1 on ischemia-reperfusion (I-R) injury to the pancreas was evaluated using isolated in vivo perfused dog pancreas. Pancreatic endocrine and exocrine functions were stimulated with 10(-12) M cholecystokinin octapeptide (CCK-8). This amount of CCK-8 promoted production of insulin, glucagon, PGI2, and thromboxane (Tx) A2 in the pancreas. Sixty minutes of ischemia and subsequent reperfusion induced damage to pancreatic ductular, acinar, and beta cells. Intra-arterial administration of PGE1 at a dose of 0.5 microgram/kg/min throughout the experiment prevented the I-R injury, reducing plasma lipid peroxides, and elevating PGI2 without changing TxA2 in the pancreas. PGE1 thus appears to protect pancreatic function from I-R injury both by depressing the effect of free-radicals and by decreasing TxA2/PGI2 which predicts cell injury.

MeSH terms

  • 6-Ketoprostaglandin F1 alpha / blood
  • Alprostadil / pharmacology*
  • Animals
  • Dogs
  • Female
  • Glucagon / blood
  • Insulin / blood
  • Lipid Peroxides / blood
  • Male
  • Pancreas / blood supply
  • Pancreas / drug effects*
  • Reperfusion Injury / prevention & control*
  • Thromboxane B2 / blood

Substances

  • Insulin
  • Lipid Peroxides
  • Thromboxane B2
  • 6-Ketoprostaglandin F1 alpha
  • Glucagon
  • Alprostadil